Psychological support system opens to infected blood victims
The nationwide service began a phased rollout in September, and is now open to people infected and affected across the country.
The Infected Blood Psychological Service will include talking therapies; peer support and psychosocial support, NHS England said.
More than 30,000 people in the UK were infected with HIV and hepatitis C after they were given contaminated blood and blood products between the 1970s and early 1990s.
And more than 3,000 people have died as a result, while survivors are living with lifelong health implications.
The new service is open to victims of the scandal as well as bereaved partners, parents, children and their extended families.
People can self refer by phone or can be referred to the service by their GP.
Officials said that a specialist therapist will help create tailored mental health plans for those in need of support.
The Infected Blood Inquiry Report is now published on the Inquiry website. Access the Report here: https://t.co/lhr9SGYlFd
— Infected Blood Inquiry (@bloodinquiry) May 20, 2024
Claire Murdoch, national mental health director at NHS England, said: 'The contaminated blood scandal and the subsequent long fight for answers have had life-altering physical and psychological impacts for thousands across the country and the NHS is determined to ensure that anyone infected or affected can receive evidence-based support and treatment.
'It has been so important that the Infected Blood Psychological Service has been co-designed with members of the infected blood community to ensure the best and most personalised care possible, and we are very grateful to all our partners who have helped establish these vital new services.'
Nicola Leahey, from Lancashire, was infected with Hepatitis C following blood transfusions in 1975 and/or 1980, and was part of the expert advisory group to the new service.
'After my diagnosis, I felt that my body had been violated, that I had been physically and mentally abused, stripped of my dignity, my self-esteem diminished, I mourned lost opportunities, I felt betrayed,' she said.
'So many of us have long awaited the opportunity to have professional support to try to cope with the trauma and life-long effects that we've been subjected to.
'I'm thrilled that this much-needed service is now operational for both those infected and affected members of the infected blood community across England.'
Professor Meghana Pandit, co-national medical director for secondary care at NHS England, added: 'Following the recommendations of the Inquiry, this new service represents a vital step in ensuring patients and families affected in England can be offered tailored psychological treatment and support, and we are pleased that specialist clinics are now open in all areas of England.
'This bespoke psychological treatment is already making a difference to the lives of the first people to access it, and we now want to ensure everyone eligible is aware of the services provided.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Rhyl Journal
an hour ago
- Rhyl Journal
ADHD waiting list led to rise in unregulated private providers
The ADHD taskforce, commissioned by NHS England with the support of the Government, has published an interim report saying the system for diagnosing and managing ADHD needs to be overhauled. At the moment, ADHD assessment and treatment in England is provided by highly specialised doctors in secondary care. But the report warned: 'Inability to access NHS services has led to a significant growth in the use of private providers that are not regulated, resulting in two-tier access to services, diagnosis and treatment; one for those who can pay and another for those who cannot. 'This drives health inequalities and links to disproportionate impacts and outcomes in the education and justice systems, employment and health.' Experts behind the study said waiting times for NHS ADHD services 'have escalated and are unacceptably long' and demand on services is 'very likely' to continue to rise. The taskforce concluded that ADHD is not solely the remit of the NHS and other health providers, with schools being vital for identifying and meeting needs at an early stage. And while a clinical diagnosis of ADHD via the NHS is required if a person needs medication, early support can still be provided to others. The report said: 'We need timely recognition and early support of suspected ADHD and neurodivergence across all settings. 'This is especially important in schools and the early years, to prevent adverse impacts and costly outcomes in the future. This should be needs-led and not require a clinical diagnosis.' The report also suggested there is no evidence of over-diagnosis of ADHD in the UK. It argued: 'England and the rest of the UK have much lower service recognition and treatment rates of ADHD diagnosis compared with other European countries. 'Recent data show a very high level of under-recognition and under-treatment of strictly diagnosed ADHD, with significant inequalities in access to care.' The report also addressed concerns about potential 'over-medicalisation and over-diagnosis', including worries that people are self-diagnosing ADHD based on information from social media. However, the report, said that 'currently there is no good evidence on what percentage of those waiting to see a clinician have self-diagnosed ADHD using social media and eventually meet or do not meet ADHD diagnostic criteria after a high-quality assessment. 'We only know currently that in England, recognised rates of ADHD are lower than the expected prevalence of ADHD.' Currently, the estimated economic costs of not treating ADHD are around £17 billion to the UK economy, the report went on. This includes through lower tax contributions, people needing state benefits and more likely to be not in education, employment or training, or who are long-term unemployed. 'Many of these costs are avoidable, as with appropriate, early support, people with ADHD can thrive,' it said. Professor Anita Thapar, chair of the ADHD Taskforce, said: 'The recommendations put forward by the taskforce will require action across Government and cross-sector organisations to make the necessary changes to improve the lives of people with ADHD. 'We need to get this right, to make sure people get early diagnosis and support, not just in the NHS but across society.' Dr Adrian James, NHS England's medical director for mental health and neurodiversity, said: 'We know that too many people with ADHD have been waiting for too long for support, which is why we launched the taskforce last year to help respond to the significant growth in the need for care. 'It is clear that much more needs to be done to improve ADHD assessment and care in England and ensure people can get a timely diagnosis, and we welcome the findings from the interim report, and look forward to its final conclusions later this year.' A Department of Health and Social Care spokesperson said: 'Lord Darzi's report into the state of the NHS laid out how severe the delays have become for people waiting for an attention deficit hyperactivity disorder diagnosis. 'We welcome the publication of the ADHD Taskforce's interim report, which provides valuable insights into the challenges affecting those with ADHD, including access to services and support.' The NHS has launched publicly-available data collection on ADHD referrals and waiting times to help local teams better understand how they are performing. By March 2026, the Government also aims for six in 10 pupils to have access to a mental health support team in school.
Daily Mail
3 hours ago
- Daily Mail
African gay men blame President Trump for their recent HIV diagnoses after he cut prevention funding
Gay men in Africa are blaming President Trump's decision to cut funding for HIV /AIDS prevention for their diagnoses of the virus. The administration's sweeping cuts to foreign aid have reduced access to medications like Pre-Exposure Prophylaxis, or PrEP, which decreases the risk of contracting HIV by 99 percent. Emmanuel Cherem, 25, a gay men in Nigeria, told Reuters that he tested positive for HIV two months after losing access to the US-supplied drug. 'I blame myself... Taking care of myself is my first duty as a person,' he said. 'I equally blame the Trump administration because, you know, these things were available, and then, without prior notice, these things were cut off.' Echezona, 30, another gay man from Nigeria, told Reuters that he took PrEP pills daily for three years until he was told by a clinic worker that the drug was now only available to pregnant and lactating women. 'I just pray and wish that Trump actually changes his policy and everything comes back to normal so that the spread and transmission of the virus would be reduced,' he said. Trump issued an executive order on his first day in office that paused foreign development assistance for 90 days, while Secretary of State Marco Rubio signed a 'stop work order' to employees of the State Department's Office of Foreign Assistance. The department oversees the US Agency for International Development (USAID) and the President's Emergency Plan for AIDS Relief (PEPFAR), which have seen drastic cuts since Trump took office. The administration has defended its position, arguing that other countries need to shoulder the burden of providing aid. During South African President Cyril Ramaphosa's White House visit, Trump acknowledged that the foreign aid cuts have been 'devastating.' 'Hopefully a lot of people are going to start spending a lot of money,' Trump added. 'I've talked to other nations. We want them to chip in and spend money too, and we've spent a lot,' he continued. 'And it's a big - it's a tremendous problem going on in many countries. A lot of problems going on. The United States always gets the request for money. Nobody else helps.' Russell Vought, the director of the US Office of Management and Budget, echoed Trump's stance during a Congressional committee meeting in early June. He argued that African countries should take on the responsibility of fighting HIV/AIDS, alleviating the financial burden on the US. Vought added that some of the nonprofits facilitating HIV prevention programs 'are not geared toward the viewpoints of the administration.' The director's comments are in line with a waiver issued to PEPFAR programs on February 1 allowing prevention programs to restart only for pregnant mothers. Vulnerable populations, like members of the LGBTQIA+ community, sex workers, or injecting drug users, weren't included in the prevention measures. PEPFAR grants often covered the cost of clinics supplying PrEP at public health centers for these populations, which have suffered closures due to decreased funding. A spokesperson for the State Department told Reuters that PEPFAR-funded programs would continue to be reviewed for 'assessment of programmatic efficiencies and consistency with United States foreign policy.' Public health officials and activists fear that if Trump's hardline policy toward foreign aid stays consistent, HIV infections will continue in the region. Linda-Gail Bekker, an HIV expert at the University of Cape Town, said that African countries may not cover the expense of supplying the drug, leaving a gap for more diagnoses. 'It's as predictable as if you take your eye off a smoldering bushfire and the wind is blowing: a bushfire will come back,' she told Reuters. Countries like Malawi, Zimbabwe, and Mozambique were almost entirely dependent on US funding for HIV prevention measures, according to UNAIDS. Other countries, like Ethiopia, responded to the USAID funding cuts by introducing a new payroll tax to pay for HIV medication previously provided by US funding. Medical advancements for HIV prevention and treatment have progressed significantly in recent years. However, UNAIDS projects that gaps created by a lack of funding could see steps backward.
The Guardian
3 hours ago
- The Guardian
One in three overdue for cervical cancer screening across UK
A third of people across the UK are overdue their cervical cancer screening, while in parts of England some are at greater risk of the disease than others due to a low uptake for the preventive vaccine, experts have warned. Since the coronavirus pandemic, cervical screening attendance rates have been steadily declining, from 72.2% in 2020 to 68.4% in 2024, NHS England data shows. A YouGov survey of 3,000 people across the UK eligible for cervical cancer screening, commissioned by Cancer Research UK, is in line with these findings, with 30% of respondents being overdue their screening. It also highlighted the main barriers people cited, with 42% of respondents finding cervical screening painful previously, 40% not wanting a man to carry out the screening test, and just under one in five (19%) of respondents saying they were too embarrassed to go for a screening. Of those who did not attend their screening, 16% of respondents said it was because they didn't have any symptoms, highlighting the misinformation still prevalent regarding cervical screening, which is for people without symptoms. Separate figures from the UK Heath Security Agency (UKHSA) have found that uptake of the HPV vaccine greatly varies by region, with girls in London by year 10 having the lowest uptake (64.9%) and girls in the south-east the highest (82.7%). Among boys of the same age, it was also lowest in London (58.9%) and highest in the south-east (77.3%). HPV refers to a group of viruses that can be transmitted through sexual contact and cause no symptoms. About 13 high-risk types of HPV are known to cause 99.7% of cervical cancers. Each year, about 3,200 women in the UK are diagnosed with cervical cancer and 850 die from it. It is the 14th most common cancer affecting women in Britain, with women aged 30 to 34 most likely to receive a diagnosis. Last year, NHS England pledged to wipe out cervical cancer by 2040. Globally, it is the fourth most common cancer in women, with about 660,000 new cases and 350,000 deaths every year, according to the World Health Organization. The disease develops when abnormal cells appear in the lining of the cervix and grow, eventually coming together as a tumour. If the cells are not caught early, the cancer can spread to other parts of the body. In June, NHS England said that women aged between 25 and 49 who test negative for HPV, meaning they are at very low risk of cervical cancer over the next 10 years, will safely be invited at five-year intervals instead of three. Fiona Osgun, Cancer Research UK's head of health information, said the declining rates were due to a combination of factors. Sign up to First Edition Our morning email breaks down the key stories of the day, telling you what's happening and why it matters after newsletter promotion 'We know that people have specific barriers to accessing screening; some of those are practical such as not being able to get an appointment at a time that works for them, but some are more specific to the test itself, such as finding the screening painful or being worried about who's going to be carrying out the test,' Osgun said. 'I think we have just seen a slow decline, which unfortunately can happen even with successful screening programmes. We need to continue to chip away at those misunderstandings and misconceptions some people have regarding cervical screening.' Osgun added that there were various measures people could ask for to make their cervical screening test more comfortable, such as asking for a double appointment or a different-sized speculum. Dr Amanda Doyle, national director for primary care and community services at NHS England, said: 'The NHS HPV vaccination programme has already helped save thousands of lives and we need to go further to boost uptake of HPV vaccines and cervical screening to help eliminate cervical cancer in England by 2040.'
